1. MicroRNA-655-3p regulates Echinacea purpurea mediated activation of ABCG2
   Charles Awortwe et al, 2017, Xenobiotica CrossRef
2. Not only P-glycoprotein: Amplification of the ABCB1- containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins
   Ilaria Genovese et al, 2017, Drug Resistance Updates CrossRef
3. Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia
   Raquel Maia et al, 2018, Molecules CrossRef
4. Myeloid leukemia with high EVI1 expression is sensitive to 5-aza-2′-deoxycytidine by targeting miR-9
   F. Li et al, 2019, Clin Transl Oncol CrossRef
5. MicroRNAs and response to therapy in leukemia
   Hossein Sharifi et al, 2019, J Cell Biochem CrossRef
6. Emerging Effects of Sepantronium Bromide (YM155) on MOLT-4 Cell Line Apoptosis Induction and Expression of Critical Genes Involved in Apoptotic Pathways
   Kobra Shojaei Moghadam et al, 2019, Adv Pharm Bull CrossRef
7. hsa-miR-9-3p and hsa-miR-9-5p as Post-Transcriptional Modulators of DNA Topoisomerase IIα in Human Leukemia K562 Cells with Acquired Resistance to Etoposide
   Evan E. Kania et al, 2020, Mol Pharmacol CrossRef
8. Diverse Targeted Approaches to Battle Multidrug Resistance in Cancer
   Nagula Shankaraiah et al, 2019, CMC CrossRef
9. The versatile nature of miR-9/9* in human cancer
   Katarzyna Nowek et al, 2018, Oncotarget CrossRef
10. Overexpression of miR‑574‑3p suppresses proliferation and induces apoptosis of chronic myeloid leukemia cells via targeting IL6/JAK/STAT3 pathway
    Haoying Yang et al, 2018, Exp Ther Med CrossRef
11. Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment
    Soudeh Ghafouri-Fard et al, 2021, Biomedicine & Pharmacotherapy CrossRef
12. miRNAs Mediated Drug Resistance in Hematological Malignancies
    Sara Peixoto da Silva et al, 2021, Seminars in Cancer Biology CrossRef
13. Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance
    Huan Xiao et al, 2021, Front. Pharmacol. CrossRef
14. MicroRNA-9-3p Aggravates Cerebral Ischemia/Reperfusion Injury by Targeting Fibroblast Growth Factor 19 (FGF19) to Inactivate GSK-3β/Nrf2/ARE Signaling
    Yadong Zhou et al, 2021, NDT CrossRef
15. Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant
    Yan Liang et al, 2021, Journal of Controlled Release CrossRef
16. ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia
    Simona Sucha et al, 2022, Biomedicine & Pharmacotherapy CrossRef
17. Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation
    Zsuzsanna Gaál, 2022, IJMS CrossRef
18. Role of MicroRNAs in Cancer Drug Resistance
    Kondapalli N. Babu et al, 2022 CrossRef
19. Downregulation of SOX21-AS1 alleviated cisplatin resistance in cervical cancer through Epithelial-messenchymal transition (EMT) inhibition
    Jing Tian et al, 2022, Rejuvenation Research CrossRef
20. Oestrogen-related receptor alpha mediates chemotherapy resistance of osteosarcoma cells via regulation of ABCB1.
    Yantao Chen et al, 2019, J Cell Mol Med CrossRef
21. MiRNAs function in the development of resistance against doxorubicin in cancer cells: targeting ABC transporters
    Xin-Yan Lu et al, 2024, Front. Pharmacol. CrossRef
22. MiRNAs: main players of cancer drug resistance target ABC transporters
    Forogh Mohammadi et al, 2025, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
23. MircoRNAs predict and modulate responses to chemotherapy in leukemic patients
    Doha El-Sayed Ellakwa et al, 2025, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef